Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Non-Current Deffered Revenue: 2020-2025

Historic Non-Current Deffered Revenue for Sotera Health (SHC) over the last 5 years, with Sep 2025 value amounting to $16.9 million.

  • Sotera Health's Non-Current Deffered Revenue fell 5.84% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year decrease of 5.84%. This contributed to the annual value of $16.8 million for FY2024, which is 10.54% down from last year.
  • Latest data reveals that Sotera Health reported Non-Current Deffered Revenue of $16.9 million as of Q3 2025, which was down 2.67% from $17.4 million recorded in Q2 2025.
  • Sotera Health's Non-Current Deffered Revenue's 5-year high stood at $21.6 million during Q2 2021, with a 5-year trough of $16.7 million in Q1 2025.
  • Moreover, its 3-year median value for Non-Current Deffered Revenue was $18.0 million (2024), whereas its average is $17.9 million.
  • Data for Sotera Health's Non-Current Deffered Revenue shows a maximum YoY fell of 10.54% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Sotera Health's Non-Current Deffered Revenue stood at $20.7 million in 2021, then declined by 8.88% to $18.9 million in 2022, then dropped by 0.74% to $18.8 million in 2023, then dropped by 10.54% to $16.8 million in 2024, then decreased by 5.84% to $16.9 million in 2025.
  • Its last three reported values are $16.9 million in Q3 2025, $17.4 million for Q2 2025, and $16.7 million during Q1 2025.